Bristol-Myers Squibb (BMY) Revenue — Quarter Ended Dec 31, 2025
Revenue increased for the quarter. The growth rate accelerated compared to the prior quarter.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue increased for the quarter. The growth rate accelerated compared to the prior quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$12.5B
Revenue reported for this quarter.
Quarter-over-quarter
+2.3%
Change from the immediately preceding quarter.
Year-over-year
+1.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$48.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $11.2B | -5.6% |
| Jun 30, 2025 | $12.3B | +0.6% |
| Sep 30, 2025 | $12.2B | +2.8% |
| Dec 31, 2025 | $12.5B | +1.3% |
Revenue performance
Revenue rose from the immediately preceding quarter. The increase was driven by higher product sales across several key therapeutic areas.
Quarterly comparison
Compared to the same quarter one year earlier, revenue also grew. The growth rate this quarter was higher than the year-over-year change seen in the prior quarter.
What to watch
Monitor whether revenue growth can be sustained given the company's significant debt position and ongoing business development activities.